C11873: Nasal Implant for Efficient Treatment of SinusitisNovelty:
Implant improves drug delivery for the treatment of sinusitis.
Value Proposition:
In the United States, about 3 to 10 million people suffer from chronic sinusitis, caused by inflammation of the paranasal sinus tissue. Common treatment methods include saline irrigation and steroids, used to alleviate symptoms, but current delivery solutions are unable to treat areas that are inaccessible due to local inflammation. This invention provides a means to easily and directly apply therapies to the sinuses. The device, which is an implanted tube, is not perceivable to the patient nor is it externally visible. Other advantages of this device include:
• Secure anchoring mechanisms with novel shape-memory arms
• Simple placement and replacement procedures performed by a physician
• Magnetic fixtures to connect to drug injectors
• Specially designed tube will avoid occlusion from surrounding tissue or mucus
Technical Details:
Johns Hopkins researchers have developed an implant for the application of drugs directly to the sinuses. The device consists of a catheter that allows drugs to reach previously inaccessible surfaces. It is easily implanted in the nasal cavity after surgery or during an office visit. The device also features a novel magnetic fixture to connect the drug injectors. This feature creates a reliable seal for efficient medication passage. The unique construction prevents inflammation from blocking delivery to areas that need treatment the most.
Looking for Partners:
To develop and commercialize the technology as an implantable device to facilitate effective treatment of chronic sinusitis.
Stage of Development:
Prototype
Data Availability:
Under CDA/NDA
Publications/Associated Cases:
None at this time.
